Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 13.9611.0922.7930.42-2.27

What is the latest EV/Core EBITDA ratio of BAFNA PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of BAFNA PHARMACEUTICALS is 13.96 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202413.96
Mar202311.09
Mar202222.79
Mar202130.42
Mar2020-2.27

How is EV/Core EBITDA of BAFNA PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 13.96
25.88
Mar2023 11.09
-51.34
Mar2022 22.79
-25.08
Mar2021 30.42
Positive
Mar2020 -2.27 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹192.0 Cr 1.3% 1.3% -8.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,920.0 Cr -0.1% 1.7% 45.7% Stock Analytics
DIVIS LABORATORIES ₹155,160.0 Cr -0.1% -2.2% 56.9% Stock Analytics
CIPLA ₹118,917.0 Cr 1.7% 0.5% 23.7% Stock Analytics
DR REDDYS LABORATORIES ₹112,017.0 Cr 5.7% 12.4% 18.5% Stock Analytics
ZYDUS LIFESCIENCES ₹97,997.1 Cr -1.4% 3.1% 44.8% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

1.3%

1.3%

-8.9%

SENSEX

-5%

0.6%

9.2%


You may also like the below Video Courses